No Recurrence of a Neuroleptic Malignant Syndrome Under Quetiapine

Australian and New Zealand Journal of Psychiatry

Volumn 37, Issue 5, 2003, Pages 627-

  Brieger, Peter ^a   Reinelt, Yvonne ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; BIPOLAR DISORDER; CASE REPORT; CONSCIOUSNESS DISORDER; DELUSION; DIAPHORESIS; DYSPHORIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; KIDNEY DYSFUNCTION; LETTER; LEUKOCYTOSIS; MALE; MENTAL DEFICIENCY; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSONISM; RECURRENT DISEASE; RESTLESSNESS; SCHIZOAFFECTIVE PSYCHOSIS; SWEAT GLAND DISEASE;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; DIAZEPAM; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; HALOPERIDOL; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOTIC DISORDERS; RECURRENCE;

EID: 0242468204     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2003.01242.x     Document Type: Article

References (5)

1. Cookson J, Taylor D, Katona C. Use of drugs in psychiatry, 5th edn. London: Gaskell, 2002.
2. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Medical Clinics of North America 1993; 77:185–202.
3. Hasan S, Buckley P. Novel antipsychotics and the neuroleptic malignant syndrome. a review and critique. American Journal of Psychiatry 1998; 155:1113–1116.
4. Sing KJ, Ramaekers GMGI, Harten PN. Neuroleptic malignant syndrome and quetiapine (letter). American Journal of Psychiatry 2002; 159:149–150.
5. Hatch CD, Lund BC, Perry PJ. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics. Pharmacotherapy 2001; 21:1003–1006.